Abstract
The inability of the body’s immune system to differentiate cancer cells from normal cells allows cancer cells to proliferate in an uncontrolled manner. Newer strategies are being researched to overcome this immunological tolerance to cancer. Provoking the body’s immune system to generate vaccines against cancer is emerging as an important type of immunotherapy to treat cancers. These cancer vaccines, which have fewer side effects, and offer great promise. Many such vaccines have been identified and several of them are under clinical trials currently.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Suggested reading
S E King, Therapeutic cancer vaccines, an emerging treatment option,Clinical Journal of Oncology Nursing, Vol. 8, No. 3, pp. 271–278, 2004.
R J Bitton, Cancer vaccines: a critical review on clinical impact,Curr Opinion in Moecular Therapeutics, Vol. 6, No. l,pp. 17–26, 2004.
R A Henderson, S Mossman, N Nairn and M A Cheever, Cancer vaccines and immunotherapies: emerging perspectives,Vaccine, Vol. 23, pp. 2359–2362, 2005.
E Puré, J P Allison and R D Schreiber, Breaking down the barriers cancer,Nature Immunology, Vol. 6, pp. 1207–1210, 2005.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vasanthi, N.S. Cancer vaccines: The new fight against cancer. Reson 11, 48–55 (2006). https://doi.org/10.1007/BF02834473
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02834473